Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayley C Whitaker

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Urology Open Science|October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic AnalysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Journal of Radiology|September 28, 2023
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefactsSaurabh Singh, Francesco Giganti, Louise Dickinson, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE studyUrszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
Scientific Reports|September 3, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Scientific Reports|November 12, 2020
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
Oncotarget|May 26, 2018
Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionHayley Pye, Mohammed Adil Butt, Laura Funnell, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Urology Open Science|October 1, 2020
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic AnalysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
European Journal of Radiology|September 28, 2023
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefactsSaurabh Singh, Francesco Giganti, Louise Dickinson, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE studyUrszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
Scientific Reports|September 3, 2020
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Scientific Reports|November 12, 2020
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancerSabina Luszczak, Benjamin S Simpson, Urszula Stopka-Farooqui, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
Oncotarget|May 26, 2018
Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionHayley Pye, Mohammed Adil Butt, Laura Funnell, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
Pageof 7